{
    "Trade/Device Name(s)": [
        "Audit\u2122M MicroCVTM Cardiac Markers Linearity Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K102617",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJY"
    ],
    "Summary Letter Date": "January 10, 2011",
    "Summary Letter Received Date": "November 23, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac",
        "misc"
    ],
    "Analyte(s)": [
        "CKMB",
        "Myoglobin",
        "Troponin I (TnI)"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Calibrator",
        "Reference Material"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u2122M MicroCVTM Cardiac Markers Linearity Set, a five-level human serum-based cardiac marker quality control for calibration verification.",
    "Indications for Use Summary": "Intended as an assayed quality control material of five human serum levels containing CKMB, Myoglobin, and Troponin I for use with quantitative assays to verify calibration, linearity, and reportable range.",
    "fda_folder": "Clinical Chemistry"
}